Int J Nephrol Renovasc Dis 3: 69-83.Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment[J] . Matt Bremmer.International Journal of Nephrology and Renovascular Disease . 2010 (defa)
Autosomal dominant polycystic kidney disease (ADPKD) is the most common of the monogenic disorders and is characterized by bilateral renal cysts; cysts in other organs including liver, pancreas, spleen, testis and ovary; vascular abnormalities including intracranial aneurysms and subarachnoid hemorrhage; ...
Fenofibrate use is associated with an elevation in serum creatinine and BUN levels41; therefore, whether this drug can be used over the long term in kidney disease patients is unclear. In conclusion, miR-17B92 promotes ADPKD progression through a new mechanism involving the inhibition of mitochon...
Chang-Gao Zhong1,2, Xiu-Rong Li1,2, Liang Hu1,2, Guang-Xiu Lu1,2, Ge Lin1,2 and Juan Du1,2* Abstract Background: Autosomal dominant polycystic kidney disease (ADPKD), the commonest inherited kidney disease, is generally caused by heterozygous mutations in PKD1, PKD2, or GANAB (PKD3...
Wu HC, Lee LC, Wang WJ (2017) Associations among serum beta 2 microglobulin, malnutrition, inflammation, and advanced cardiovascular event in patients with chronic kidney disease. J Clin Lab Anal 31(3):e22056. https://doi.org/10.1002/jcla.22056 Article CAS PubMed Google Scholar Zhao D, ...
BACKGROUND:With the expanding understanding of conditions contributing to heightened cardiovascular risk, emerging pathologies like nonalcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) are being recognized as hepatic and ovarian
International Journal of Molecular Sciences Review Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease Cassandra Millet-Boureima 1 , Stephanie He 1, Thi Bich Uyen Le 1,2 and Chiara Gamberi 3,* 1 Department of Biology, Concordia University, Montreal, QC H4B 1R6, ...
In addition, the presence of the PKD2 gene mutation in these patients could be an indicator of a milder disease course [20]. The utility of serum creatinine in stable renal function has made this endogenous marker to be used worldwide as a marker of kidney function. The revised Schwartz ...
In addition, the presence of the PKD2 gene mutation in these patients could be an indicator of a milder disease course [20]. The utility of serum creatinine in stable renal function has made this endogenous marker to be used worldwide as a marker of kidney function. The revised Schwartz ...
In addition, the presence of the PKD2 gene mutation in these patients could be an indicator of a milder disease course [20]. The utility of serum creatinine in stable renal function has made this endogenous marker to be used worldwide as a marker of kidney function. The revised Schwartz ...